Botulinum Toxin Type A (BOTOX®) Treatment of Masseter Muscle Hypertrophy
Status:
Completed
Trial end date:
2017-11-29
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of a range of doses of botulinum toxin Type
A (BOTOX®) for the treatment of patients with bilateral Masseter Muscle Hypertrophy (MMH).
Phase:
Phase 2
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA